Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Meta-Analysis
. 2023 Sep 27;11(4):333-341.
doi: 10.1093/sxmrev/qead023.

The impact of cell-based therapy on female sexual dysfunction: a systematic review and meta-analysis

Russell G Saltzman  1 , Katherine G Campbell  2 , Sarah J Ripps  3 , Roei Golan  3 , Maria A Cabreja-Castillo  1 , Ana Maria Garzon  1 , Farah Rahman  2 , Lina V Caceres  1 , Jairo A Tovar  1 , Aisha Khan  1 , Joshua M Hare  1   4 , Ranjith Ramasamy  1   2
Affiliations
Meta-Analysis

The impact of cell-based therapy on female sexual dysfunction: a systematic review and meta-analysis

Russell G Saltzman et al. Sex Med Rev. .

Abstract

Introduction: Female sexual dysfunction (FSD) is a complex issue affecting women of all ages; it involves several overlapping body systems and profoundly affects quality of life. The use of cell-based therapy, such as mesenchymal stem cells, has recently been investigated as a potential treatment for FSD.

Objectives: This systematic review and meta-analysis aim to assess FSD outcomes following cell-based therapy.

Methods: We evaluated peer-reviewed articles from multiple online databases through November 2022 to identify studies that used cell-based therapy and reported sexual function outcomes in women. We performed a meta-analysis using data pooled from 3 clinical trials at our institution: CRATUS (NCT02065245), ACESO (NCT02886884), and CERES (NCT03059355). All 3 trials collected data from the Sexual Quality of Life-Female (SQOL-F) questionnaire as an exploratory outcome.

Results: Existing literature on this topic is scarce. Five clinical studies and 1 animal study were included in the systematic review, and only 2 clinical studies were considered good quality: 1 reported significant SQOL-F improvement in women 6 months after cell therapy, and 1 reported posttherapy sexual satisfaction in all women. When individual patient data were pooled in a meta-analysis from 29 women across 3 trials at our institution, the SQOL-F was not significantly improved.

Conclusion: Despite growing interest in cell-based therapy for women's sexual health, this important issue is understudied in the literature. The optimal route, source, and dose of cell therapy to produce clinically meaningful change have yet to be determined, and further research is needed in larger randomized placebo-controlled clinical trials.

Keywords: cell-based therapy; female sexual dysfunction; mesenchymal stem cells; regenerative medicine; restorative therapy; stem cell therapy.

PubMed Disclaimer

Figures

Figure 1
Figure 1
Systematic review: PRISMA diagram.
Figure 2
Figure 2
Sexual Quality of Life–Female questionnaire results from the CRATUS randomized placebo-controlled trial.
See this image and copyright information in PMC

References

    1. Allahdadi KJ, Tostes RC, Webb RC. Female sexual dysfunction: therapeutic options and experimental challenges. Cardiovasc Hematol Agents Med Chem. 2009;7(4):260–269. - PMC - PubMed
    1. Parish SJ, Cottler-Casanova S, Clayton AH, McCabe MP, Coleman E, Reed GM. The evolution of the female sexual disorder/dysfunction definitions, nomenclature, and classifications: a review of DSM, ICSM, ISSWSH, and ICD. Sex Med Rev. 2021;9(1):36–56. - PubMed
    1. Parish SJ, Hahn SR, Goldstein SW, et al. The International Society for the Study of Women’s Sexual Health process of care for the identification of sexual concerns and problems in women. Mayo Clin Proc. 2019;94(5):842–856. - PubMed
    1. McCabe MP, Sharlip ID, Atalla E, et al. Definitions of sexual dysfunctions in women and men: a consensus statement from the Fourth International Consultation on Sexual Medicine 2015. J Sex Med. 2016;13(2):135–143. - PubMed
    1. Derogatis LR, Komer L, Katz M, et al. Treatment of hypoactive sexual desire disorder in premenopausal women: efficacy of flibanserin in the VIOLET study. J Sex Med. 2012;9(4):1074–1085. - PubMed

Publication types